STOCK TITAN

Global Medical REIT Inc. Announces Retirement of Ronald Marston from its Board of Directors and Declares 2025 Fourth Quarter Common and Preferred Dividends

(Neutral)
(Neutral)
Tags
management dividends

Key Terms

cumulative redeemable preferred stock financial
Cumulative redeemable preferred stock is a type of investment that gives shareholders priority over common stockholders to receive dividends and get their money back if the company is sold or closes. If the company misses dividend payments, it must pay them later before any dividends can go to other shareholders. This makes it a more secure and flexible option for investors seeking steady income with some ability to redeem their shares in the future.
par value financial
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.
Series A Preferred Stock financial
Series A preferred stock is a type of ownership share in a company that gives investors certain advantages, such as priority in receiving profits or getting their money back if the company is sold or goes bankrupt. It is often issued during early funding stages to attract investors by offering more security than common shares. This stock matters to investors because it provides a safer way to invest while still holding potential for future gains.
Series B Preferred Stock financial
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
record as of financial
"Record as of" indicates the specific date or point in time when a particular financial figure or statistic was measured or confirmed. It helps investors understand the exact moment when the data was valid, similar to taking a snapshot of a situation. This clarity is important for making accurate comparisons and informed decisions based on the most current or relevant information.
independent director financial
An independent director is a member of a company's board of directors who is not involved in the company's day-to-day operations and has no significant relationships with the company that could influence their judgment. Their role is to provide unbiased oversight and ensure the company is managed in the best interests of all shareholders. This helps build trust and confidence among investors by promoting transparency and accountability.
Nominating and Corporate Governance Committee financial
A nominating and corporate governance committee is a group within a company's board of directors responsible for selecting and recommending individuals to serve as company leaders, such as directors or executives. They also develop and oversee policies to ensure the company is run fairly, ethically, and transparently. This committee matters to investors because it helps ensure the company is well-managed and guided by qualified, responsible leadership.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

BETHESDA, Md.--(BUSINESS WIRE)-- Global Medical REIT Inc. (NYSE: GMRE) (the “Company” or “GMRE”) today announced that Ronald Marston has notified the Board of Directors (the “Board”) that he plans to retire as a member of the Board at the end of his current term and that the Board has declared the Company’s 2025 fourth quarter common and preferred dividends.

Ronald Marston’s Retirement from Board of Directors

Mr. Marston has served on the Board since 2015 as an independent director and at different points throughout his tenure has served as the chair of the Board’s Nominating and Corporate Governance Committee as well as a member of the Board’s Audit and Compensation Committees. Mr. Marston’s retirement will be effective at the end of his current term, which will conclude at the Company’s Annual Meeting of Stockholders to be held in 2026.

Lori Wittman, the Board’s lead independent director commented, “the Board would like to thank Ron for his leadership and significant contributions throughout his service as a director. Ron provided an outstanding example of the ethical, respectful, and engaged way all board members should act. We all wish Ron a happy and enjoyable retirement.”

Common Dividend

The Board has declared the Company’s 2025 fourth quarter cash dividend of $0.75 per share of common stock and unit (the “Common Dividend”). The Common Dividend is payable on January 9, 2026, to common stockholders and unitholders of record as of December 19, 2025.

Series A Preferred Dividend

The Board has also declared a quarterly cash dividend of $0.46875 per share on its Series A Cumulative Redeemable Preferred Stock, $0.001 par value per share (the “Series A Preferred Stock”), which is payable on February 2, 2026, to Series A Preferred stockholders of record as of January 15, 2026. This represents the Company’s quarterly dividend on its Series A Preferred Stock for the period from October 31, 2025 through January 30, 2026.

Series B Preferred Dividend

The Board has also declared a quarterly cash dividend of $0.388 per share on its Series B Cumulative Redeemable Preferred Stock, $0.001 par value per share (the “Series B Preferred Stock”), which is payable on February 2, 2026, to Series B Preferred stockholders of record as of January 15, 2026. This represents the Company’s initial, pro rata dividend on its Series B Preferred Stock for the period from its issuance on November 20, 2025 through January 30, 2026.

About Global Medical REIT Inc.

Global Medical REIT Inc. is a net-lease medical REIT that acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.

Additional information on GMRE can be obtained on its website at www.globalmedicalreit.com.

Forward-Looking Statements

Certain statements contained herein may be considered “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and it is the Company’s intent that any such statements be protected by the safe harbor created thereby. These forward-looking statements are identified by their use of terms and phrases such as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "should," "plan," "predict," "project," "will," "continue" and other similar terms and phrases, including references to assumptions and forecasts of future results. Except for historical information, the statements set forth herein including, but not limited to, any statements regarding the Company’s expected dividend payments and board composition are forward-looking statements. These forward-looking statements are based on our current expectations, estimates and assumptions and are subject to certain risks and uncertainties. Although the Company believes that the expectations, estimates and assumptions reflected in its forward-looking statements are reasonable, actual results could differ materially from those projected or assumed in any of the Company’s forward-looking statements. Additional information concerning us and our business, including additional factors that could materially and adversely affect our financial results, include, without limitation, the risks described under Part I, Item 1A - Risk Factors, in our Annual Report on Form 10-K, our Quarterly Reports on Form 10-Q, and in our other filings with the SEC. You are cautioned not to place undue reliance on forward-looking statements. The Company does not intend, and undertakes no obligation, to update any forward-looking statement.

Investor Relations:
Email: Investors@globalmedicalreit.com
Phone: 202.524.6869

Source: Global Medical REIT Inc.